The short version
14 companies supply this market — deep enough that no single failure threatens the supply.
Market view
27 marketed package NDCs · 14 active manufacturers
Most dispensed: Kit · #1 kit/kit * 6 ml in 1 vial * 2 ml in 1 syringe · 100 ug/mL · Injection, Solution · #10 vials/carton / 1 ml in 1 vial · 200 ug/mL · Injection, Solution · #1 vial, multi-dose/carton / 5 ml in 1 vial, multi-dose · 100 ug/mL · Injection, Solution · #10 vial, single-doses/tray / 1 ml in 1 vial, single-dose
14 companies supply this market — deep enough that no single failure threatens the supply.
Every detected change for octreotide acetate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in Somatostatin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.